|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-9-29
|
|
pubmed:abstractText |
Treatment of recurrent and progressive meningiomas remains a challenge in clinical neurooncology. This study was designed to evaluate the efficacy of the simultaneous application of 3d-conformal radiotherapy and chemotherapy with hydroxyurea (HU).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0167-594X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-65
|
|
pubmed:meshHeading |
pubmed-meshheading:16193387-Administration, Oral,
pubmed-meshheading:16193387-Adult,
pubmed-meshheading:16193387-Aged,
pubmed-meshheading:16193387-Antineoplastic Agents,
pubmed-meshheading:16193387-Combined Modality Therapy,
pubmed-meshheading:16193387-Disease Progression,
pubmed-meshheading:16193387-Female,
pubmed-meshheading:16193387-Follow-Up Studies,
pubmed-meshheading:16193387-Humans,
pubmed-meshheading:16193387-Hydroxyurea,
pubmed-meshheading:16193387-Male,
pubmed-meshheading:16193387-Meningeal Neoplasms,
pubmed-meshheading:16193387-Meningioma,
pubmed-meshheading:16193387-Middle Aged,
pubmed-meshheading:16193387-Neoplasm Recurrence, Local,
pubmed-meshheading:16193387-Pilot Projects,
pubmed-meshheading:16193387-Radiotherapy, Conformal,
pubmed-meshheading:16193387-Remission Induction,
pubmed-meshheading:16193387-Survival Rate
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University Hospitals of Erlangen, 91054 Erlangen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Review
|
